Filter News
Area of Research
- (-) Nuclear Science and Technology (22)
- Advanced Manufacturing (21)
- Biology and Environment (33)
- Building Technologies (3)
- Clean Energy (123)
- Climate and Environmental Systems (1)
- Computational Engineering (3)
- Computer Science (15)
- Electricity and Smart Grid (2)
- Energy Sciences (1)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (1)
- Fusion and Fission (12)
- Fusion Energy (7)
- Isotope Development and Production (1)
- Isotopes (11)
- Materials (48)
- Materials for Computing (10)
- Mathematics (1)
- National Security (22)
- Neutron Science (15)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (5)
- Sensors and Controls (1)
- Supercomputing (63)
News Type
News Topics
- (-) 3-D Printing/Advanced Manufacturing (2)
- (-) Computer Science (1)
- (-) Cybersecurity (1)
- (-) Isotopes (3)
- (-) Nuclear Energy (19)
- (-) Space Exploration (4)
- (-) Sustainable Energy (1)
- Advanced Reactors (7)
- Bioenergy (1)
- Biomedical (2)
- Decarbonization (1)
- Environment (1)
- Fusion (2)
- Materials Science (1)
- Molten Salt (3)
- Neutron Science (4)
- Physics (1)
- Transformational Challenge Reactor (1)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.